Validation of α‐Synuclein in <scp>L1CAM</scp>‐Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes
Cheng Jiang(Shenzhen Institute of Information Technology), George K. Tofaris(University of Oxford), Andrea Pilotto(Fondazione Europea Ricerca Biomedica), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Jason J. Davis(University of Oxford), Barbara Borroni(Centro San Giovanni di Dio Fatebenefratelli), Franziska Hopfner(German Center for Neurodegenerative Diseases)
Cited by 127
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846